Proteomics, multi-omics, ADCs and protein degradation are driving demand for site-specific labeling, cell-based assays and outsourced conjugation services.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- ...
Precision medicine, clinical genomics, multi-omics and advanced therapies are driving demand for automation, bioinformatics and recurring reagents despite budget and talent constraints.Dublin, Sept.
Opportunities span AI-enabled discovery, multi-omics, precision medicine, advanced therapies, biomarker-led trials, data platforms, CRO partnerships and Asia-Pacific expansionDublin, Sept. 22, 2026 ...